Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Varex Imaging (VREX) Cash & Equivalents (2016 - 2026)

Varex Imaging (VREX) has disclosed Cash & Equivalents for 11 consecutive years, with $119.5 million as the latest value for Q1 2026.

  • On a quarterly basis, Cash & Equivalents fell 32.1% to $119.5 million in Q1 2026 year-over-year; TTM through Jan 2026 was $119.5 million, a 32.1% decrease, with the full-year FY2025 number at $145.0 million, down 14.05% from a year prior.
  • Cash & Equivalents was $119.5 million for Q1 2026 at Varex Imaging, down from $145.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $205.1 million in Q2 2025 to a low of $81.5 million in Q4 2022.
  • A 5-year average of $134.5 million and a median of $138.8 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: plummeted 48.35% in 2022, then surged 73.37% in 2023.
  • Varex Imaging's Cash & Equivalents stood at $81.5 million in 2022, then soared by 73.37% to $141.3 million in 2023, then increased by 19.39% to $168.7 million in 2024, then decreased by 14.05% to $145.0 million in 2025, then fell by 17.59% to $119.5 million in 2026.
  • Per Business Quant, the three most recent readings for VREX's Cash & Equivalents are $119.5 million (Q1 2026), $145.0 million (Q4 2025), and $136.4 million (Q3 2025).